Chondrosarcomas, malignant cartilaginous neoplasms, are capable of transitioning to highly aggressive, metastatic, and treatment-refractory states, resulting in significant patient mortality.
Here, we aim to uncover the transcriptional program…
News
Constitutive activation of EGFR is associated with tumor progression and plays a prominent role in malignant phenotype of chondrosarcoma Jun Qin,1 Irfan Shaukat,1 Didier Mainard,1 Patrick Netter,1 Lydia Barré,1 and Mohamed Ouzzine1 Author…
Chondrosarcoma Patient Registry
HomepageOn November 30 the Chondrosarcoma will conduct the first full statistical analysis of the Chondrosarcoma Patient Registry. The analysis will focus on detailed patient profiling. In… Read Article
Videos from Virtual Dialogue 5 are posted on the Web Site. We invite you to go to the Chondrosarcoma Foundation web site to review the presentations and the open discussion from the Fifth International Virtual Dialogue recently held on October 4….
New Publication: Chondrosarcoma: What You Need to Know A third publication created by the Chondrosarcoma Foundation’s Patient, Family, Caregiver Advisory Board and the Marketing / Graphics team at Inhibrx provides straightforward information on…
Steppin’ For A Cause: 5K Walk / Run October 21, 2023 10:00AM EST Allen’s Pond, Bowie, Maryland Please join us for our annual fund raising event to honor Shayna Kramer by carrying out her wish to help others that have the same rare bone cancer:…
Future Initiatives in the Diagnosis and Treatment of Chondrosarcoma Chondrosarcoma Foundation: Fifth International Virtual Dialogue (VIA Zoom) Date: Wednesday, October 4, 2023 Time: 7:00PM – 9:00PM (EST / New York) Last chance to register. The…